Amicus Theraputics



Amicus Therapeutics is a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. We have a unique set of platform technologies and medicines in development for patients living with the Lysosomal Storage Disorders. 

The Amicus footprint spans 27 countries including our global headquarters in Cranbury, NJ and international headquarters in Marlow UK. Additional international office locations include Canada, Germany, Italy, The Netherlands, Spain, France, and Japan.